Literature DB >> 11959140

Crystal structure of human nicotinamide mononucleotide adenylyltransferase in complex with NMN.

Erik Werner1, Mathias Ziegler, Felicitas Lerner, Manfred Schweiger, Udo Heinemann.   

Abstract

The final step in the biosynthesis of nicotinamide-adenine dinucleotide, a major coenzyme in cellular redox reactions and involved in intracellular signaling, is catalyzed by the enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT). The X-ray structure of human NMNAT in complex with nicotinamide mononucleotide was solved by the single-wavelength anomalous dispersion method at a resolution of 2.9 A. Human NMNAT is a symmetric hexamer whose subunit is formed by a large six-stranded parallel beta-sheet with helices on both sides. Human NMNAT displays a different oligomerization compared to the archaeal enzyme. The protein-nicotinamide mononucleotide interaction pattern provides insight into ligand binding in the human enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959140     DOI: 10.1016/s0014-5793(02)02556-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship.

Authors:  Lucia Brunetti; Michele Di Stefano; Silverio Ruggieri; Flavio Cimadamore; Giulio Magni
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

Review 2.  Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme.

Authors:  Rong Grace Zhai; Menico Rizzi; Silvia Garavaglia
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

3.  Bifunctional NMN adenylyltransferase/ADP-ribose pyrophosphatase: structure and function in bacterial NAD metabolism.

Authors:  Nian Huang; Leonardo Sorci; Xuejun Zhang; Chad A Brautigam; Xiaoqing Li; Nadia Raffaelli; Giulio Magni; Nick V Grishin; Andrei L Osterman; Hong Zhang
Journal:  Structure       Date:  2008-02       Impact factor: 5.006

Review 4.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

5.  Structure of nicotinic acid mononucleotide adenylyltransferase from Bacillus anthracis.

Authors:  Shanyun Lu; Craig D Smith; Zhengrong Yang; Pamela S Pruett; Lisa Nagy; Deborah McCombs; Lawrence J Delucas; Wayne J Brouillette; Christie G Brouillette
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-09-30

6.  Nicotinamide mononucleotide adenylyltransferase displays alternate binding modes for nicotinamide nucleotides.

Authors:  Roland Pfoh; Emil F Pai; Vivian Saridakis
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-09-26

Review 7.  The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions.

Authors:  Carlo Fortunato; Francesca Mazzola; Nadia Raffaelli
Journal:  IUBMB Life       Date:  2021-12-05       Impact factor: 4.709

8.  Structural genomics of human proteins--target selection and generation of a public catalogue of expression clones.

Authors:  Konrad Büssow; Christoph Scheich; Volker Sievert; Ulrich Harttig; Jörg Schultz; Bernd Simon; Peer Bork; Hans Lehrach; Udo Heinemann
Journal:  Microb Cell Fact       Date:  2005-07-05       Impact factor: 5.328

Review 9.  New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases.

Authors:  Keun Woo Ryu; Dae-Seok Kim; W Lee Kraus
Journal:  Chem Rev       Date:  2015-01-09       Impact factor: 60.622

10.  Structural insights into Plasmodium falciparum nicotinamide mononucleotide adenylyltransferase: oligomeric assembly.

Authors:  Luis Ernesto Contreras-Rodríguez; Catherin Yizet Marin-Mogollon; Lina Marcela Sánchez-Mejía; María Helena Ramírez-Hernández
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-07-10       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.